Jain N, Zhao Z, Feucht J, Koche R, Iyer A, Dobrin A, Mansilla-Soto J, Yang J, Zhan Y, Lopez M, Gunset G, Sadelain M. TET2 guards against unchecked BATF3-induced CAR T cell expansion. Nature. 2023 Mar;615(7951):315-322.
- Commentary: Wagner DL, Mamonkin M. Splendid isolation. Blood. 2023 Jun 1;141(22):2665-2666. [PMID: 37261853]
Odak A, Yuan H, Feucht J, Cantu VA, Mansilla-Soto J, Kogel F, Eyquem J, Everett JK, Bushman FD, Leslie C, Sadelain M. Novel extragenic genomic safe harbors for precise therapeutic T cell engineering. Blood. 2023 Feb 6:blood. [PMID: 36745870]
Mansilla-Soto J, Eyquem J, Haubner S, Hamieh M, Feucht J, Paillon N, Zucchetti AE, Li Z, Sjöstrand M, Lindenbergh PL, Saetersmoen M, Dobrin A, Maurin M, Iyer A, Garcia Angus A, Miele MM, Zhao Z, Giavridis T, van der Stegen SJC, Tamzalit F, Rivière I, Huse M, Hendrickson RC, Hivroz C, and Sadelain M. HLA-independent T cell receptors for targeting tumors with low antigen density. Nature Medicine. January 13, 2022. [PMID: 35027758]
- Commentary: Crunkhorn S. Driving CARs to clear senescent cells. Nat Rev Drug Discov. 2020 Aug;19(8):509.
- Commentary: Wagner V, Gil J.T cells engineered to target senescence. Nature. 2020 Jul;583(7814):37-38.
June CH, Sadelain M. Chimeric Antigen Receptor Therapy. N Engl J Med. 2018 Jul 5;379(1):64-73.